Prostate Carcinoma
139
39
65
40
Key Insights
Highlights
Success Rate
77% trial completion
Published Results
14 trials with published results (10%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.6%
12 terminated out of 139 trials
76.9%
-9.6% vs benchmark
4%
6 trials in Phase 3/4
35%
14 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (139)
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
The Vanguard Study: Testing a New Way to Screen for Cancer
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy
Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring